Finance

Lists
Why is 543904 down 3,39%?
Dive Deeper
543904:BOM
Mankind Pharma Ltd
2 275,00 ₹
-3,39%
(-79,80) 1D
16 հոկ, 15:50:40 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 543904...
Open
2 354,60 ₹
High
2 355,00 ₹
Low
2 269,00 ₹
Mkt. cap
937,40 մլրդ
Avg. vol.
40,89 հզր
Volume
32,86 հզր
P/E ratio
46,03
52-wk high
2 640,30 ₹
52-wk low
1 909,90 ₹
EPS
49,42 ₹
No. of employees
20 հզր
Open
2 354,60 ₹
High
2 355,00 ₹
Low
2 269,00 ₹
Mkt. cap
937,40 մլրդ
Avg. vol.
40,89 հզր
Volume
32,86 հզր
P/E ratio
46,03
52-wk high
2 640,30 ₹
52-wk low
1 909,90 ₹
EPS
49,42 ₹
No. of employees
20 հզր
News stories
From web sources and news partners
Profile
Mankind Pharma is an Indian multinational pharmaceutical and healthcare product company, headquartered in Delhi. The company has products in therapeutic areas ranging from antibiotics, to gastrointestinal, cardiovascular, dermal, and erectile dysfunction medications. As of 2023, Mankind Pharma had 25 factories and 6 R&D centres in India. The company derived 97% of its operating revenue from the Indian market, where it is reportedly the fourth largest pharmaceutical company by domestic sales. Some of Mankind Pharma's consumer healthcare brands are the largest-selling in their respective categories, including Manforce in condoms, Prega News in pregnancy test kits, and Unwanted-72 in emergency contraception. Wikipedia
About Mankind Pharma Ltd
CEORajeev Juneja | Sheetal Arora
Employees20,5 հզր
Founded1991
Headquarters-
Sector-
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
36,97 մլրդ
35,67 մլրդ
34,43 մլրդ
40,31 մլրդ
Cost of goods sold
10,62 մլրդ
9,78 մլրդ
11,71 մլրդ
10,98 մլրդ
Cost of revenue
10,62 մլրդ
9,78 մլրդ
11,71 մլրդ
10,98 մլրդ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
8,25 մլրդ
8,24 մլրդ
15,80 մլրդ
9,14 մլրդ
Operating expense
19,35 մլրդ
18,92 մլրդ
14,77 մլրդ
21,02 մլրդ
Total operating expenses
29,98 մլրդ
28,70 մլրդ
26,48 մլրդ
32,00 մլրդ
Operating income
7,00 մլրդ
6,97 մլրդ
7,95 մլրդ
8,30 մլրդ
Other non operating income
918,70 մլն
727,50 մլն
-2,31 մլրդ
450,00 մլն
EBT including unusual items
6,24 մլրդ
5,09 մլրդ
6,59 մլրդ
7,69 մլրդ
EBT excluding unusual items
6,24 մլրդ
6,16 մլրդ
5,59 մլրդ
7,69 մլրդ
Income tax expense
1,04 մլրդ
951,20 մլն
997,50 մլն
1,95 մլրդ
Effective tax rate
16,64%
18,69%
15,13%
25,39%
Other operating expenses
8,88 մլրդ
8,46 մլրդ
-3,26 մլրդ
9,63 մլրդ
Net income
5,12 մլրդ
4,09 մլրդ
5,54 մլրդ
5,68 մլրդ
Net profit margin
13,84%
11,46%
16,10%
14,09%
Earnings per share
12,38
11,99
13,89
13,74
Interest and investment income
-
-
580,50 մլն
-
Interest expense
-1,70 մլրդ
-1,57 մլրդ
-1,36 մլրդ
-1,10 մլրդ
Net interest expenses
-1,70 մլրդ
-1,57 մլրդ
-778,20 մլն
-1,10 մլրդ
Depreciation and amortization charges
2,22 մլրդ
2,23 մլրդ
2,23 մլրդ
2,26 մլրդ
EBITDA
9,20 մլրդ
8,42 մլրդ
9,97 մլրդ
10,33 մլրդ
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google Apps